Leffler Scott J. bought MYGN

January 29, 2024 · Form 4 insider transaction

Leffler Scott J. bought 117,770 shares of Myriad Genetics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 0 days after the transaction.

Direction
Acquired (buy-side)
Shares
117,770
Price
$0.00
Total value
N/A
Role
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateJanuary 29, 2024
Filing dateJanuary 29, 2024
Shares owned after117,770
OwnershipDirect
10b5-1 planNo
AmendedNo

Footnotes

Consists of time-based restricted stock units granted pursuant to the Company's 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock and vests in four equal annual installments beginning on the first anniversary of the grant date.

View the original Form 4 on SEC EDGAR